skip link
skip to main content
dropdown menu
SIGN UP
About Us
Science and Technology
Pipeline
Investors and Media
Contact Us
Perspectives
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Platform Technology
Science
Posters
Publications
subpage banner
Targeting glucocerebrosidase with structurally targeted allosteric regulators corrects abnormal phenotypes in models of Parkinson’s disease
Details
Written by:
web web
Category:
Events
Published: 12 April 2022
Hits: 206
Event
April 12
th
- 15
th
2022 11:20 – 11:50 a.m. ET
Learn More
Previous article: B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
Prev
Next article: Cantor Rare Orphan Disease Summit
Next
